Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neimark

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Life Sciences|June 4, 2021
Effects of three types of bariatric interventions on myocardial infarct size and vascular function in rats with type 2 diabetes mellitusOleg V Kornyushin, Dmitry L Sonin, Alexander S Polozov, et al.
Tsitologiia|September 7, 2018
ITLN1, PPARg AND TNFa GENE EXPRESSION IN VISCERAL ADIPOSE TISSUET S Usenko, V V Miroshnikova, E A Bazhenova, et al.
Journal of Crohn'S & Colitis|February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential SolutionsMathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Implementation Science : IS|September 11, 2019
Correction to: A repeated cross-sectional study of clinicians' use of psychotherapy techniques during 5 years of a system-wide effort to implement evidence-based practices in PhiladelphiaRinad S Beidas, Nathaniel J Williams, Emily M Becker-Haimes, et al.
Implementation Science : IS|June 23, 2019
A repeated cross-sectional study of clinicians' use of psychotherapy techniques during 5 years of a system-wide effort to implement evidence-based practices in PhiladelphiaRinad S Beidas, Nathaniel J Williams, Emily M Becker-Haimes, et al.
Plos One|February 25, 2026
Protocol for testing global neuronal workspace and integrated information theories of consciousness in non-human primates and miceMatilda Gibbons, Ethan G McBride, Raghuram Holenarasipura Venkatasubbaiah, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
JAMA|July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical TrialsEdouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Lancet (London, England)|June 1, 2022
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trialMarc Ferrante, Remo Panaccione, Filip Baert, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Life Sciences|June 4, 2021
Effects of three types of bariatric interventions on myocardial infarct size and vascular function in rats with type 2 diabetes mellitusOleg V Kornyushin, Dmitry L Sonin, Alexander S Polozov, et al.
Tsitologiia|September 7, 2018
ITLN1, PPARg AND TNFa GENE EXPRESSION IN VISCERAL ADIPOSE TISSUET S Usenko, V V Miroshnikova, E A Bazhenova, et al.
Journal of Crohn'S & Colitis|February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential SolutionsMathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Implementation Science : IS|September 11, 2019
Correction to: A repeated cross-sectional study of clinicians' use of psychotherapy techniques during 5 years of a system-wide effort to implement evidence-based practices in PhiladelphiaRinad S Beidas, Nathaniel J Williams, Emily M Becker-Haimes, et al.
Implementation Science : IS|June 23, 2019
A repeated cross-sectional study of clinicians' use of psychotherapy techniques during 5 years of a system-wide effort to implement evidence-based practices in PhiladelphiaRinad S Beidas, Nathaniel J Williams, Emily M Becker-Haimes, et al.
Plos One|February 25, 2026
Protocol for testing global neuronal workspace and integrated information theories of consciousness in non-human primates and miceMatilda Gibbons, Ethan G McBride, Raghuram Holenarasipura Venkatasubbaiah, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
JAMA|July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical TrialsEdouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Lancet (London, England)|June 1, 2022
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trialMarc Ferrante, Remo Panaccione, Filip Baert, et al.
Pageof 27